Coding for a patient who gets subsequent infusions of infliximab
Search results for: infliximab
Dermatology Case Answer C: May
C) Tumor necrosis factor (TNF)–α-induced palmoplantar pustular psoriasis
ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome
Research has led to greater understanding of the disease, potential for better treatment options
ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy
Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Tech Talk: Contraption Reduces Pain of Rheumatic Therapy Injections
Innovative device called Buzzy applies high-frequency vibration sensation and cold to soothe sting of shots
ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists
Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 38
- Next Page »